{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-004539","form_type":"8-K","ticker":"BCAB","cik":"0001826892","company_name":"BioAtla, Inc.","filed_at":"2024-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.776438+00:00","generated_at":"2026-06-07T02:32:31.809290+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"BioAtla amends bylaws to align with DGCL changes and add universal proxy rules","bullets":["Board approved amended and restated bylaws on Jan 5, 2024; effective immediately.","Revised advance notice procedures, restricts nominee count, and requires compliance with Rule 14a-19.","Added emergency bylaw provision, electronic notice updates, and proxy card color rule for stockholder solicitations.","Ministerial and clarifying changes to conform to DGCL and SEC regulations."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-004539","json":"https://secwatch.observer/filing/0001193125-24-004539.json","markdown":"https://secwatch.observer/filing/0001193125-24-004539.md","text":"https://secwatch.observer/filing/0001193125-24-004539.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826892/000119312524004539/0001193125-24-004539-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826892/000119312524004539/d689996d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T02:32:31.809290+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a1115cfa5f88c1386d983b61a2a820c071afd9e9","claim":"BioAtla, Inc.: Amended and restated bylaws to conform to Delaware law, update advance notice provisions, and address universal proxy rules (effective 2024-01-05).","evidence_excerpt":"On January 5, 2024, the board of directors (the “Board”) of BioAtla, Inc. (the “Company”) approved and adopted an amendment and restatement of the Company’s Amended and Restated Bylaws (the “Amended and Restated Bylaws”), which became immediately effective.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1826892/000119312524004539/0001193125-24-004539-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2024-01-05"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}